Oct. 16 Financial Quick Takes: Hong Kong IPO could value Ascentage at $876M; plus Principia, Rhythm, ProQR, dMed, Ionova and Amarna

Ascentage sets Hong Kong IPO terms
Ascentage Pharma Group International would raise HK$404.4 million ($51.6 million) and be valued at HK$6.9 billion ($876.4 million) if it prices its Hong Kong IPO at the

Read the full 335 word article

How to gain access

Continue reading with a
two-week free trial.